What are the barriers to implementing national antimicrobial resistance action plans? A novel mixed-methods policy analysis in Pakistan

Author:

Khan Mishal S1,Durrance-Bagale Anna1,Mateus Ana2,Sultana Zia3,Hasan Rumina34,Hanefeld Johanna1ORCID

Affiliation:

1. Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1H 9SH, UK

2. Department of Pathobiology and Population Sciences, Royal Veterinary College, London WC1H 9SH, UK

3. Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi 74800, Pakistan

4. Faculty of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London WC1H 9SH, UK

Abstract

Abstract Despite political commitment to address antimicrobial resistance (AMR), countries are facing challenges to implementing policies to reduce inappropriate use of antibiotics. Critical factors to the success of policy implementation in low- and middle-income countries (LMIC), such as capacity for enforcement, contestation by influential stakeholders and financial interests, have been insufficiently considered. Using Pakistan as a case study representing a populous country with extremely high antibiotic usage, we identified 195 actors who affect policies on antibiotic use in humans and animals through a snowballing process and interviewed 48 of these who were nominated as most influential. We used a novel card game-based methodology to investigate policy actors’ support for implementation of different regulatory approaches addressing actions of frontline healthcare providers and antibiotic producers across the One Health spectrum. We found that there was only widespread support for implementing hard regulations (prohibiting certain actions) against antibiotic suppliers with little power—such as unqualified/informal healthcare providers and animal feed producers—but not to target more powerful groups such as doctors, farmers and pharmaceutical companies. Policy actors had limited knowledge to develop implementation plans to address inappropriate use of antibiotics in animals, even though this was recognized as a critical driver of AMR. Our results indicate that local political and economic dynamics may be more salient to policy actors influencing implementation of AMR national action plans than solutions presented in global guidelines that rely on implementation of hard regulations. This highlights a disconnect between AMR action plans and the local contexts where implementation takes place. Thus if the global strategies to tackle AMR are to become implementable policies in LMIC, they will need greater appreciation of the power dynamics and systemic constraints that relate to many of the strategies proposed.

Funder

Pump Prime Award by the UK AMR Cross Council Initiative under ESRC

Publisher

Oxford University Press (OUP)

Subject

Health Policy

Reference34 articles.

1. Pharmaceutical drug promotion practices in Pakistan: issues in ethical & non-ethical pharmaceutical practices;Ahmed;Middle East Journal of Scientific Research,2014

2. Innovation in regulation of rapidly changing health markets;Bloom;Globalization and Health,2014

3. Antimicrobial resistance and universal health coverage;Bloom;BMJ Global Health,2017

4. Exploring the evidence base for national and regional policy interventions to combat resistance;Dar;The Lancet,2016

5. In urban and rural India, a standardized patient study showed low levels of provider training and huge quality gaps;Das;Health Affairs,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3